Free Trial
LON:POLB

Poolbeg Pharma (POLB) Share Price, News & Analysis

Poolbeg Pharma logo
GBX 2.70 0.00 (-0.07%)
As of 04/17/2025 11:22 AM Eastern

About Poolbeg Pharma Stock (LON:POLB)

Key Stats

Today's Range
2.53
2.75
50-Day Range
2.40
5.05
52-Week Range
2.25
15.77
Volume
621,453 shs
Average Volume
2.21 million shs
Market Capitalization
£13.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Poolbeg Pharma plc is a clinical-stage biopharmaceutical company focussed on the development of innovative medicines to address unmet medical needs. Poolbeg comprises a strong and growing portfolio of development assets.

Receive POLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Poolbeg Pharma and its competitors with MarketBeat's FREE daily newsletter.

POLB Stock News Headlines

Here’s How to Claim Your Stake in Elon’s Private Company, xAI
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.
Hookipa Pharma to acquire Poolbeg Pharma
Poolbeg Pharma’s POLB 001 Shows Promise in CRS Treatment
See More Headlines

POLB Stock Analysis - Frequently Asked Questions

Poolbeg Pharma's stock was trading at GBX 7.10 at the beginning of the year. Since then, POLB stock has decreased by 62.0% and is now trading at GBX 2.70.
View the best growth stocks for 2025 here
.

Shares of POLB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Poolbeg Pharma investors own include EQTEC (EQT), Great Western Mining (GWMO), Power Metal Resources (POW), Premier African Minerals (PREM), Rolls-Royce Holdings plc (RR), Alzamend Neuro (ALZN) and Alpine 4 (ALPP).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:POLB
CIK
N/A
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£-4,500,219,166.67
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
GBX 1.28 per share
Price / Cash Flow
2.11
Book Value
GBX 2,489.80 per share
Price / Book
0.00

Miscellaneous

Free Float
N/A
Market Cap
£13.87 million
Optionable
Not Optionable
Beta
2.11

This page (LON:POLB) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners